Hormone Deficiencies in Cancer Survivors MEMS Annual Congress (MAC) May 2013
|
|
- Cory Bruce
- 5 years ago
- Views:
Transcription
1 Hormone Deficiencies in Cancer Survivors MEMS Annual Congress (MAC) May 2013 Dr. Fuziah Md. Zain Paediatric Department
2
3 Content Introduction Chronic health problems late effects Endocrine late effects Screening and monitoring Recommendation Conclusion
4 Introduction - 1 Effective treatment of childhood cancer / malignancy by paediatric oncologists. Increasing numbers of children become long-term cancer survivors. In British Columbia, 3,000 patients, > 17 yrs old, survivors of childhood cancer (1). Each year, >120 patients graduate to become adult survivors. USA : 1 of every 640 adults, years is a childhood cancer survivor (Oeffinger KC 2006). The 5-year cure rate for cancer is nearly 80% (2) Cure rates exceed 90% for ALL and Hodgkin s disease (3,4) 1) Lauren M, ) Bhatia S, ) Cohen LE, ) Marina N, 1997
5 Introduction - 2 Many survivors face long-term negative health. Many are unaware of the specific cancer therapy they received. They do not know that they may face significant long-term risks to their health & well-being (6) A need for evidence-based surveillance of the long-term effects of cancer therapy. Nearly 2/3 of all childhood cancer survivors will suffer some late effects. The endocrine system is commonly involved (5,6) 1) Lauren M, ) Sklar C ) Oeffinger KC 2006
6 Childhood Cancer Survivors 40% : may have endocrine disturbances related to underlying malignancy, surgery, radiation therapy or chemotherapy (4,6). These factors are modified by the age at which treatment was initiated, the length of time since treatment and gender (3,7) Late effects are more severe in children in comparison to survivors of adult cancers. Why? Cancer treatment is received during periods of growth & development (1). 1) Lauren M, ) Sklar C ) Gleeson HK ) Meacham L 2003
7 Childhood Cancer Survivors Acute lymphoblastic leukaemia (ALL) survivors reported more adverse general & mental health, functional impairment, & activity limitations compared with siblings (P < 0.001). Rates of marriage, college graduation, employment, and health insurance were all lower compared with sibling controls (P < 0.001). Long-term survivors of childhood ALL exhibit excess mortality & morbidity. Rajen M, Blood 2008
8
9 Severity of overall & specific late effects according to risk factors JW Han, 2009
10 Late Effects Health Endocrine Cardiovascular (cardiac toxicity, coronary disease, vascular damage, CVA) Pulmonary Kidney Neurologic toxicity Neurocognitive dysfunction Recurrence of original disease Second neoplasms Post-traumatic stress disorder Late deafness Non health related Education poor educational outcome Social consequences Lauren M, BCMJ Vol 52, 2010; Rajen M et al, Blood 2008, JW Han 2009
11 JW Han, 2009
12 JW Han, 2009
13 Second Neoplasms Radiation exposure increases the risk for : Brain tumours Breast cancer Thyroid cancer Bone tumours Soft tissue sarcoma Exposure to alkylating agent & topoisomerase II inhibitors: Myeloid malignancy Myelodysplastic syndromes Benign meningiomas Lauren M 2010
14 Endocrine Late Effects Growth problems Hypothyroidism Hyperthyroidism Thyroid nodules Central adrenal insufficiency Precocious puberty Gonadotrophin deficiency Delayed puberty Premature menopause Infertility, obstetrical problems Hyperprolactinaemia Low bone mineral density Overweight / obese Metabolic syndrome, dyslipidaemia Lauren M 2010 Figure from Health Link, Children s Oncology Group
15 Studies Childhood Cancer Survivor Study (CCSS) - USA Pediatric Oncology AfterCare Program (Pediatric Oncology Group of Ontario) - Canada The Childhood, Adolescent, Young Adult Cancer Survivorship Research Program (CAYACS) British Columbia Long-term Follow-up Clinic (LTFUC) South Korea
16 Target Organ Irradiation Cranial irradiation includes cranial, orbital/eye, ear/infratemporal & nasopharyngeal Thyroid irradiation includes thyroid, neck, cervical spine, oropharyngeal, supraclavicular, mantle and mini mantle Gonadal radiation includes lumbosacral spine, abdomen and pelvis (females) and pelvis and testicular (males) Target organ irradiation has the most pronounced endocrine late effects
17 Cranial Radiation There is well-established association between the total radiation dose & development of pituitary hormone deficiencies. The GH axis is the most sensitive of the hypothalamic functions to radiation. Dose : >18 Gy Dose >40 Gy : gonadotropin, corticotropin, thyrotropin secretion may be compromised. Age of patient at the time of diagnosis and RT may affect degree of hypothalamic-pituitary damage sustained. Younger age : more deleterious effect on hypothalamaic-pituitary axis. Shalet SM 1976; Constine 1993; Brownstein CM 2004; Costin G 1988, Gleeson HK 2004, Radha N 2007.
18 Gonadal Radiation & Total Body Irradiation (TBI) TBI The effects of TBI parallel those of cranial & craniospinal RT TBI & haematopoietic cell transplantation are most often utilised as salvage therapy after primary cancer failure. Cumulative effect of aggressive use of multiagent cancer therapy - Endocrine dysfunction - Increased risk of metabolic syndrome (absence of overweight/ obesity) Ovarian TBI, abdominal, pelvic & lumbosacral irradiation especially in postpubertal female. can compromise ovarian function. Increased risk of premature menopause. High risk : Dose of radiation of >10 Gy and high dose alkylating agents. Sklar C 2005
19 Gonadal Radiation & Total Body Irradiation (TBI) Testes are particularly sensitive to irradiation. Germ cells suffer more damage compared to Leydig cells at lower levels of radiation. The efffect of testicular irradiation is highly dosedependent. Dose (Gy) Effects 1-3 Azoospermia may be reversible 3-6 Azoospermia is less likely reversible > 6 Permanent azoospermia >20 Leydig cell damage & affect testosterone production Howell SJ, 2001&2005 : Kenney LB, 2001;
20 Chemotherapy Effects of chemotherapeutic agents on the endocrine system are less extensive than radiation. Gonadal dysfunction, dyslipidaemia, osteopaenia / osteoporosis Alkylating agents, heavy metals, non-classical alkylators cause dose-related male & female gonadal dysfunction. Alkylating agents : busulfan, procarbazine, mechlorethamine, cyclophosphamide are gonadotoxic. Cumulative cyclophosphamide dose >7.5 mg/m2 : highest risk of gonadal toxicity. Combination of chemotherapy with testicular, pelvic or TBI significantly increases the gonadal dysfunction. Afify Z, 2000; Muller J 2002
21 Proposed screening & monitoring the potential late effects based on The Children s Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent and Young Adult Cancers (COG LTFUG) Radha N, Caroline L, Daniel M, Melissa H, Lilian M Horm Res 2008;69:65-74, 2008
22
23 Endocrine Late Effects Growth problems Hypothyroidism Hyperthyroidism Thyroid nodules Central adrenal insufficiency Precocious puberty Gonadotrophin deficiency Delayed puberty Premature menopause Infertility Hyperprolactinaemia Low bone mineral density Overweight / obese Metabolic syndrome, dyslipidaemia
24 Growth Problems History Assess nutritional status Physical frequency Every 6 months until growth complete Every 6 months until sexually mature History frequency Physical Every 6 months Height & weight BMI Tanner staging Further considerations when to refer If poorly growing: bone age & TFT Refer to endocrine: if height/weight <P3, drop >2 percentile channels, growth 4-5 cm/year Lack of pubertal growth spurt If GH deficiency, consider DEXA
25 Hypothyroidism: Central and Primary Radiation doses >10 Gy in the region of the thyroid à Hypothyroidism, rarely hyperthyroidism History & Frequency Fatigue, weight gain Cold intolerance Cobstipation Dry skin, brittle hair, depressed mood Repeat history yearly Lab studies Lab frequency Free T4 TSH Yearly Physical Height & weight Hair, skin Thyroid exam Further considerations when to refer Refer to endocrine for thyroid hormone replacement
26 Hyperthyroidism History Heat intolerance Tachycardia, palpitations Weight loss, emotional lability Muscle weakness Hyperphagia Lab studies Free T4 TSH History frequency Yearly Lab frequency Yearly Physical & frequency Eyes, skin Thyroid Cardiac Neurologic Yearly Further considerations when to refer Refer to endocrine for management of hyperthyroidism
27 Thyroid nodule Physical Physical frequency Thyroid exam Yearly Radiation doses >25 Gy --> thyroid nodules Radiation to the neck --> thyroid cancer Further considerations when to refer Ultrasound & FNA for nodule Refer to endocrine & surgery for biopsy & thyroidectomy Nuclear ablation for ablation Refer to endocrine for postop management
28 Central adrenal insufficiency Cranial RT At radiation dose >40Gy, ACTH axis may be affected to varying degrees. Lab studies 8.00 am cortisol History Failure to thrive, anorexia Dehydration, hypoglycaemia Lethargy unexplained Hypotension Lab frequency Yearly for 15 years until off therapy History frequency Yearly Further considerations When to refer If morning cortisol <10 ug/dl, refer to endocrine for further evaluation & treatment.
29 Precocious Puberty (PP) Cranial RT & Puberty Radiation dose >18 Gy à true PP, early puberty, normally-timed puberty Risk factor : female, younger age at treatment Lab studies Lab frequency LH, FSH Testosterone / oestradiol Prn signs of early puberty Physical Physical frequency Height & weight Tanner staging Testicular volume Yearly until sexually mature Further considerations When to refer If rapidly growing bone age Refer to endocrine if accelerated puberty in girls <8 yo, boys <9 yo
30 Gonadotropin deficiency, Delayed Puberty, Premature Menopause, Infertility - Females Cranial RT & Puberty Radiation dose >40 Gy Delay in puberty through gonadotropin deficiency Lab studies LH, FSH Oestradiol History Physical & frequency Pubertal (onset, tempo) Menstrual/pregnancy history Sexual function (vaginal dryness, libido) Medication use impacting sexual function Elicit history yearly Tanner stage Yearly until sexually mature Lab frequency Further considerations When to refer Begin at 13 yrs & prn Consider DEXA Refer to endocrine if delayed puberty Refer to reproductive endocrine for infertility
31 Fertility of female survivors of childhood cancer Childhood Cancer Survivor Study (CCSS) Review of 5,149 female participants in CCSS, 5-year survivors. 1,441 female siblings of CCSS participants age years. The relative risk for survivors of ever being pregnant was 0.81 (95% CI, 0.73 to 0.90, p <0.001) compared with female siblings. Those who received hypothalamic/pituitary radiation dose >30 Gy or an ovarian/uterine radiation dose >5Gy were less likely to have ever been pregnant (RR 0.56 for 5-10 Gy, 95% CI, , RR 0.18 for >10 Gy 95% CI, ) Daniel M. Green et al, J Clin Oncol 27: , 2009
32 Gonadotropin deficiency, Delayed Puberty, Infertility - Males Cranial RT & Puberty At radiation dose >40 Gy à may delay through gonadotropin deficiency Lab studies LH, FSH Testosterone Semen analysis History Physical & frequency Pubertal (onset, tempo) Sexual function (erections, nocturnal emissions, libido) Medication use impacting sexual function Elicit history yearly Tanner stage Testicular volume Yearly until sexually mature Lab frequency Further considerations When to refer Begin at 14 yrs and prn Consider DEXA Refer to endocrine if delayed/arrested puberty Refer to reproductive endocrine for infertility Consider inhibin B
33 Hyperprolactinaemia Notes Radiation dose >40 Gy, mid-brain surgery or tumour in hypothalamic area à hyperprolactinaemia It interferes with pulsatile secretion of GnRH Lab studies Prolactin History Physical & frequency Galactorrhoea Decrease libido Menstrual history (females) To assess yearly Tanner stage Testicular volume Yearly until sexually mature Lab frequency Further considerations When to refer prn CT of sella Refer to endocrine if hyperprolactinaemia, galatorrhoea, amenorrhoea
34 Potential Late Effects Low bone mineral density Notes Lab Studies & frequency Further consideration when to refer Adverse effect from antimetabolite agents (methotrexate, corticosteroids) Altered bone metabolism (hinder acquisition of peak bone mass) Baseline Bone density evaluation DEXA or qualitative CT Refer to endocrine if osteoporosis T score >2.5 SD or history of multiple fractures Notes Lab studies & frequency Dyslipidaemia Heavy metals as carboplatin & cisplatin cause dyslipidaemia Fasting lipid profile Baseline (entry into a long term follow-up program)
35 Overweight and Obesity Cranial RT History Physical & frequency It leads to weight management issues Risk factors : - Females - children <4 yo - hypothalamic radiation dose >18 Gy Overweight : - Age 2-20 : BMI >P Age >21 : BMI Obese : - Age 2-20 : BMI >P95 - Age >21 : BMI >30 Height & weight, BMI BP Yearly Lab studies Lab frequency Further considerations When to refer FBS Fasting serum insulin Fasting lipid profile Every 2 yrs in overweight / obese patients Every 5 years in normal weight patients Refer to endocrine if insulin resistance / metabolic syndrome Nutrition, cardiology referrals
36 Care of Childhood Cancer Survivor (CCS) Comprehensive follow-up care strategy is needed. Many cancer centres have comprehensive, long-term follow-up clinics where interdisciplinary teams screen for late effects based on published guidelines (1) Source of referral to paediatric endocrinologists. Life long surveillance should be supported by an ongoing registry for adult survivors of childhood cancer Vital facts : diagnosis, treatment, risk category for late effects, monitor any subsequent health problems (2) 1) Landier W ) Lauren M 2010
37 Surveillance Monitoring All survivors should have a medical summary details of diagnosis & therapy. Counseling (by nurse practitioners, physicians) anticipated health risks. Survivors should consent to annual contact (directly or via GP) for F/U of their health. Provide risk-based guidelines to patients & health care professionals. Hewitt M, 2005; Lauren M 2010
38 General Recommendations - 1 Education on healthy lifestyle Minimize the added effects of obesity on CVD Minimize the risk of malignancy associated with obesity. Anthracyclines therapy ECHO to measure EF & fractional shortening ECG every 5 years. Chest radiation (female) Mammography or MRI breast screening starting at age 25. Kremer LC 2001, Steinherz LJ, 1992, Lalonde L 2005, Lee CH 2005
39 General Recommendations - 2 Radiation to the brain Screen for benign meningiomas MRI starting 10 yrs post-treatment Radiation to the thyroid Pelvic radiation Screen for thyroid nodules Perform US neck starting 5 yrs posttreatment TFT T4 & TSH Risk of infertility Premature menopause Early pregnancy loss & premature delivery (uterine insufficiency) Winther JF 2008, Reulen RC 2009, Lauren M 2010
40
41
42
43 Conclusion The most common late effects were associated with the endocrine system. The timely & appropriate recognition of the endocrine sequelae can dramatically improve the QoL of these survivors. Many questions about the late endocrine effects of childhood cancer therapy remain unanswered. Cancer survivors must be continuously monitored after the completion of cancer treatment. A program is needed to provide life-long health surveillance, counseling and a registry for this population.
44 Thank you
Chapter 4. Managing Fertility in Childhood Cancer Patients T.K. Woodruff and K.A. Snyder (eds.) Oncofertility. Springer 2007
Chapter 4 Managing Fertility in Childhood Cancer Patients T.K. Woodruff and K.A. Snyder (eds.) Oncofertility. Springer 2007 The original publication of this article is available at www.springerlink.com
More informationCancer and Fertility Ashley Munchel, MD Assistant Professor of Pediatrics University of Maryland Medical Center
Cancer and Fertility Ashley Munchel, MD Assistant Professor of Pediatrics University of Maryland Medical Center Trends in Pediatric Cancer Incidence Rates by Site, Ages Birth to 19 Years, 1975 to 2010.
More informationFemale Health Issues after Treatment for Childhood Cancer
Female Health Issues after Treatment for Childhood Cancer The effects of childhood cancer therapy on female reproductive function depend on many factors, including the girl s age at the time of cancer
More informationEvidence tables from the systematic literature search for premature ovarian insufficiency surveillance in female CAYA cancer survivors.
Evidence tables from the systematic literature search for premature ovarian insufficiency surveillance in female CAYA cancer survivors. Who needs surveillance? Chiarelli et al. Early menopause and Infertility
More informationFemale Gonadal Toxicity Surveillance Harmonization: Formulation of Recommendations
Female Gonadal Toxicity Surveillance Harmonization: Formulation of Recommendations Chair: Riccardo Haupt (I) Hamish Wallace (UK) Coordinator: Wendy van Dorp (NL) Guideline KNOWLEDGE/ EVIDENCE RECOMMENDATION
More informationDisturbances of female reproductive system in survivors of childhood cancer
Disturbances of female reproductive system in survivors of childhood cancer Assoc. Prof. Zana Bumbuliene VU Faculty of Medicine Clinic of Obstetrics and Gynaecology 13 SEP 2014 Introduction Cancer is the
More informationWhy? What? When? How? Dr C Fryer FRCPC) Surveillance
Why? What? When? How? Dr C Fryer FRCPC) Surveillance 1 Disclosure; Disclosure; None. I have no conflicts. I have no industry financial relationships. Background: Relapse is the single most likely late
More informationMedical Late Effects of Childhood Cancer
Medical Late Effects of Childhood Cancer Robert Goldsby Associate Professor of Clinical Pediatric UCSF Late Mortality in 5+ Year Survivors 1.00 US Female US Male Survival function estimate 0.70 0.75 0.80
More informationThe Adolescent: A Patient at Risk: Ovarian Failure in Adolescent Cancer Survivors
The Adolescent: A Patient at Risk: Ovarian Failure in Adolescent Cancer Survivors Avner Hershlag MD Professor and Chief Center for Human Reproduction North Shore LIJ Hofsra university School of Medicine
More informationEndocrine Late Effects in Survivors of Pediatric SCT
Endocrine Late Effects in Survivors of Pediatric SCT Daphna Hutt Pediatric Hem-Onc & BMT Sheba Medical Center, Israel #EBMT2015 www.ebmt.org Stiller CA (2007). Childhood Cancer In Britain. Oxford University
More informationFemale Health Issues after Treatment for Childhood Cancer
after Treatment for Childhood Cancer The effects of childhood cancer therapy on female reproductive function depend on many factors, including the girl s age at the time of cancer therapy, the specific
More informationLaura Stewart, MD, FRCPC Clinical Associate Professor Division of Pediatric Endocrinology University of British Columbia
Precocious Puberty Laura Stewart, MD, FRCPC Clinical Associate Professor Division of Pediatric Endocrinology University of British Columbia Faculty Disclosure Faculty: Laura Stewart No relationships with
More informationPEDIATRIC & ADOLESCENT CANCER SURVIVORSHIP. Denise Rokitka, MD, MPH
PEDIATRIC & ADOLESCENT CANCER SURVIVORSHIP Denise Rokitka, MD, MPH Objectives Describe incidence of childhood cancer and survival rates and causes of early mortality. Understand the late effects of cancer
More information06-Mar-17. Premature menopause. Menopause. Premature menopause. Menstrual cycle oestradiol. Premature menopause. Prevalence ~1% Higher incidence:
Menopause Dr Sonia Davison MBBS FRACP PhD Endocrinologist and Clinical Fellow, Jean Hailes for Women s Health Women s Health Research Program, Monash University = the last natural menstrual period depletion
More informationChildhood Cancer Survivor study Study Proposal: Chronic Endocrine Disorders in Cancer Survivors February 2014
Childhood Cancer Survivor study Study Proposal: Chronic Endocrine Disorders in Cancer Survivors February 2014 1. STUDY TITLE: Chronic endocrine disorders in adult survivors of childhood cancer: A Report
More informationLong term toxicity of treatment. Laurence Brugieres Children and Adolescent Oncologic department
Long term toxicity of treatment Laurence Brugieres Children and Adolescent Oncologic department Most TYA with cancer are cured from their malignancy TRAMA 2016 2 What are the consequences of cancer treatment?
More informationEndocrinological Outcome Among Treated Craniopharyngioma Patients
Endocrinological Outcome Among Treated Craniopharyngioma Patients Afaf Al Sagheir, MD Head & Consultant, Section of Endocrinology/Diabetes Department of Pediatrics KFSH&RC Introduction Craniopharyngiomas
More informationTranscript. Late complications: Endocrinology. June 2017 PROFESSOR MARGARET ZACHARIN ENDOCRINOLOGIST CONSULTANT 00:00:04 00:00:23 00:00:28 00:00:45
Transcript Late complications: Endocrinology June 2017 00:00:04 PROFESSOR MARGARET ZACHARIN ENDOCRINOLOGIST CONSULTANT I m Margaret Zacharin. I m a Paediatric and Adult Endocrinologist. I work primarily
More informationWhy is my body not changing? Conflicts of interest. Overview 11/9/2015. None
Why is my body not changing? Murthy Korada Pediatrician, Pediatric Endocrinologist Ridge Meadows Hospital Surrey Memorial Hospital None Conflicts of interest Overview Overview of normal pubertal timing
More information2.0 Synopsis. Lupron Depot M Clinical Study Report R&D/09/093. (For National Authority Use Only) to Part of Dossier: Name of Study Drug:
2.0 Synopsis Abbott Laboratories Individual Study Table Referring to Part of Dossier: Name of Study Drug: Volume: Abbott-43818 (ABT-818) leuprolide acetate for depot suspension (Lupron Depot ) Name of
More informationPedsCases Podcast Scripts
PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on the Approach to Pediatric Anemia and Pallor. These podcasts are designed to give medical students an overview of key
More informationOverview of Reproductive Endocrinology
Overview of Reproductive Endocrinology I have no conflicts of interest to report. Maria Yialamas, MD Female Hypothalamic--Gonadal Axis 15 4 Hormone Secretion in the Normal Menstrual Cycle LH FSH E2, Progesterone,
More informationOptimizing Fertility and Wellness After Cancer. Kat Lin, MD, MSCE
Optimizing Fertility and Wellness After Cancer Kat Lin, MD, MSCE University Reproductive Care University of Washington Nov. 6, 2010 Optimism in Numbers 5-year survival rate 78% for all childhood cancers
More informationREPRODUCTIVE HEALTH IN YOUNG ADULT CANCER SURVIVORS
REPRODUCTIVE HEALTH IN YOUNG ADULT CANCER SURVIVORS Laxmi A Kondapalli, MD MSCE Colorado Center for Reproductive Medicine Disclosure The speaker has no financial or other conflict of interest Objectives
More informationHormonal Control of Human Reproduction
Hormonal Control of Human Reproduction Bởi: OpenStaxCollege The human male and female reproductive cycles are controlled by the interaction of hormones from the hypothalamus and anterior pituitary with
More informationPedsCases Podcast Scripts
PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on Puberty and Pubertal Disorders Part 2: Precocious Puberty. These podcasts are designed to give medical students an overview
More informationLate Effects in Pediatric Cancer Survivors
Late Effects in Pediatric Cancer Survivors LISA K OPP, DO ASSOCIATE PROFESSOR THE UNIVERSITY OF ARIZONA DEPARTMENT OF PEDIATRICS DIVISION OF HEMATOLOGY/ONCOLOGY/BMT Objectives Review Childhood Cancer and
More informationPITUITARY: JUST THE BASICS PART 2 THE PATIENT
PITUITARY: JUST THE BASICS PART 2 THE PATIENT DISCLOSURE Relevant relationships with commercial entities none Potential for conflicts of interest within this presentation none Steps taken to review and
More informationMore than meets the eye
More than meets the eye Ana Paula Abreu, MD, PhD American Association of Clinical Endocrinologists New England Chapter Annual Meeting September 8, 2018 Disclosures No conflict of interest or significant
More informationSAMPLE. Survivorship Care Plan for Lymphoma (Diffuse Large B-Cell) General Information. Care team
SAMPLE This Survivorship Care Plan will facilitate cancer care following active treatment. It may include important contact information, a treatment summary, recommendations for follow-up care testing,
More informationUpdated Analysis of Non-Surgical Premature Menopause in the Childhood Cancer Survivor Study
Analysis Concept Proposal 1. Study Title Updated Analysis of Non-Surgical Premature Menopause in the Childhood Cancer Survivor Study 2. Working Group and Investigators CCSS Working Group: Chronic Disease
More informationReproductive Health and Pituitary Disease
Reproductive Health and Pituitary Disease Janet F. McLaren, MD Assistant Professor Division of Reproductive Endocrinology and Infertility Department of Obstetrics and Gynecology jmclaren@uabmc.edu Objectives
More information5/2/2016. Caring for Adolescents and Young Adults with Cancer. Objectives. AYA Oncology. Cancer Incidence: SEER 18, , ages
Objectives Caring for Adolescents and Young Adults with Cancer Oncology Nursing: Planting Seeds of Hope and Healing May 4 th, 2016 Describe distinctive aspects of disease biology in AYA population List
More informationOBJECTIVES. Rebecca McEachern, MD. Puberty: Too early, Too Late or Just Right? Special Acknowledgements. Maryann Johnson M.Ed.
1 Puberty: Too early, Too Late or Just Right? Maryann Johnson M.Ed., BSN, RN Special Acknowledgements Rebecca McEachern, MD OBJECTIVES Illustrate basic endocrine system and hormonal pathways Define the
More informationCancer Prevention & Control in Adolescent & Young Adult Survivors
+ Cancer Prevention & Control in Adolescent & Young Adult Survivors NCPF Workshop July 15-16, 2013 Patricia A. Ganz, MD UCLA Schools of Medicine & Public Health Jonsson Comprehensive Cancer Center + Overview
More informationSURVIVORSHIP WITH LYMPHOMA APRIL SHAMY MD,CM JEWISH GENERAL HOSPITAL MCGILL UNIVERSITY
SURVIVORSHIP WITH LYMPHOMA APRIL SHAMY MD,CM JEWISH GENERAL HOSPITAL MCGILL UNIVERSITY Some Statistics Approximately 1 in 2 Canadians develop cancer 25% of Canadians die of cancer 2009: 810,000 Canadians
More informationLate Effects of Transplants: Lessons learned and strategies to improve the health of the HCT survivor
Late Effects of Transplants: Lessons learned and strategies to improve the health of the HCT survivor Saro Armenian, DO, MPH Associate Professor, Departments of Pediatrics and Population Sciences Director,
More informationPrecocious Puberty. Disclosures. No financial disclosures 2/28/2019
Precocious Puberty Bracha Goldsweig, MD Pediatric Endocrinologist Children s Hospital and Medical Center, Omaha, NE University of Nebraska Medical Center Disclosures No financial disclosures 1 Objectives
More informationEndocrine Abnormalities in Aging Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
Endocrine Abnormalities in Aging Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study Sogol Mostoufi-Moab, University of Pennsylvania Kristy Seidel, Fred Hutchinson Cancer Research
More informationPlan Now, Parent Later
Plan Now, Parent Later A GUIDE TO Fertility Preservation Options for Males 1 Authors Lisa Bashore, PhD APRN CPNP CPON Barbara Lockart, DNP APN/CNP CPON Contributors Barb Carr, MSN CPNP Debra Schmidt,
More informationFERTILITY & TCM. On line course provided by. Taught by Clara Cohen
FERTILITY & TCM On line course provided by Taught by Clara Cohen FERTILITY & TCM FERTILITY AND TCM THE PRACTITIONER S ROLE CAUSES OF INFERTILITY RISK FACTORS OBJECTIVES UNDERSTANDING TESTS Conception in
More informationMale Health Issues after Cancer Treatment
Male Health Issues after Cancer Treatment The effects of childhood cancer therapy on male reproductive function depend on many factors, including the boy s age at the time of cancer therapy, the specifi
More informationPituitary Adenomas: Evaluation and Management. Fawn M. Wolf, MD 10/27/17
Pituitary Adenomas: Evaluation and Management Fawn M. Wolf, MD 10/27/17 Over 18,000 pituitaries examined at autopsy: -10.6% contained adenomas (1.5-27%) -Frequency similar for men and women and across
More informationPUBERTY. Preetha Krishnamoorthy. Division of Pediatric Endocrinology
PUBERTY Preetha Krishnamoorthy Division of Pediatric Endocrinology Case 1 8-year-old girl referred for breast development noted by mom What do you want to know? Normal or abnormal? What if this was an
More informationa) Study Title: The impact of chronic disease on health care utilization in the CCSS cohort
Analysis Concept Proposal a) Study Title: The impact of chronic disease on health care utilization in the CCSS cohort b) Working Group Investigators This proposed project will be developed through the
More informationEndocrine complications in long-term survivors of childhood cancers
REVIEW Endocrine-Related Cancer (2010) 17 R141 R159 Endocrine complications in long-term survivors of childhood cancers Wassim Chemaitilly and Charles A Sklar 1 Division of Endocrinology, Department of
More informationLate Effects of Transplants: Lessons learned and strategies to improve the health of the HCT survivor
Late Effects of Transplants: Lessons learned and strategies to improve the health of the HCT survivor Saro Armenian, DO, MPH Associate Professor, Departments of Pediatrics and Population Sciences Director,
More informationCoping with Pediatric Post-transplant Issues. K. Scott Baker, MD, MS Director, Pediatric Blood and Marrow Transplant and Survivorship Programs
Coping with Pediatric Post-transplant Issues K. Scott Baker, MD, MS Director, Pediatric Blood and Marrow Transplant and Survivorship Programs Risk Factors for Late Complications Pre-HCT exposures and comorbidities
More informationThe Patient with Turner s syndrome: Care in the Adult Clinic. Dr Siobhán McQuaid Consultant Endocrinologist Mater Misericordiae University Hospital
The Patient with Turner s syndrome: Care in the Adult Clinic Dr Siobhán McQuaid Consultant Endocrinologist Mater Misericordiae University Hospital Talk outline The care of the adult patient with Turner
More informationThyroid Problems after Cancer Treatment
Thyroid Problems after Cancer Treatment Some people who were treated for cancer during childhood may develop endocrine (hormone) problems as a result of changes in the function of a complex system of glands
More informationDr Stella Milsom. Endocrinologist Fertility Associates Auckland. 12:30-12:40 When Puberty is PCO
Dr Stella Milsom Endocrinologist Fertility Associates Auckland 12:30-12:40 When Puberty is PCO Puberty or Polycystic Ovary Syndrome? Stella Milsom Endocrinologist Auckland DHB, University of Auckland,
More informationLate complications after hematopoietic stem cell transplant in adult patients
Late complications after hematopoietic stem cell transplant in adult patients Gérard Socié, MD, PhD Hematology/Transplantation, Hospital Saint Louis, Paris, France Synopsis H S C T Allogeneic HSCT activity
More informationBreast Cancer in Childhood Cancer Survivors: The Impact of Screening on Morbidity
Breast Cancer in Childhood Cancer Survivors: The Impact of Screening on Morbidity WORKING GROUP: This report will be written within the Cancer Control Working Group with oversight from the Second Malignant
More informationKey Words. Childhood cancer survivors Late effects Evaluation for late effects Long-term follow-up guidelines
The Oncologist Pediatric Oncology Cancer Survivorship: A Pediatric Perspective WENDY LANDIER,SMITA BHATIA Department of Population Sciences, City of Hope Cancer Center, Duarte, California, USA Key Words.
More informationChildhood Cancer Survivor Study Study Proposal: Male Health Questionnaire (MHQ) and CED February 2015
Childhood Cancer Survivor Study Study Proposal: Male Health Questionnaire (MHQ) and CED February 2015 1. STUDY TITLE: Cyclophosphamide Equivalent Dosing and Male Health Late Effects Infertility, Erectile
More informationChildhood Cancer Survivor Study - Concept Proposal Date: September, 2014
Childhood Cancer Survivor Study - Concept Proposal Date: September, 2014 Title: Impact of Endocrine disorders on Health-Related Quality of Life and Physical Activity in Childhood Cancer Survivors: A Report
More informationPituitary for the General Practitioner. Marilyn Lee Consultant physician and endocrinologist
Pituitary for the General Practitioner Marilyn Lee Consultant physician and endocrinologist Pituitary tumours Anterior/posterior pituitary Extension of adenoma upwards/downwards/sideways Producing too
More informationGynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy
Gynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy Stephanie Yap, M.D. University Gynecologic Oncology Northside Cancer Institute Our Learning Objectives Review survival rates,
More informationClinical evaluation of infertility
Clinical evaluation of infertility DR. FARIBA KHANIPOUYANI OBSTETRICIAN & GYNECOLOGIST PRENATOLOGIST Definition: inability to achieve conception despite one year of frequent unprotected intercourse. Male
More informationPituitary Stalk Interruption Syndrome. Leena Shahla, MD, PGY5 Endocrinology, Diabetes and Metabolism Fellowship University of Massachusetts
Pituitary Stalk Interruption Syndrome Leena Shahla, MD, PGY5 Endocrinology, Diabetes and Metabolism Fellowship University of Massachusetts 11/12/2016 Case: NP, 42 year old female, from Dominican Republic.
More informationSpontaneous recovery of ovarian function and fertility after cancer treatment
Rigshospitalet The Fertility Clinic Copenhagen, Denmark Spontaneous recovery of ovarian function and fertility after cancer treatment Kirsten Tryde Macklon, Ph.D. 5th society of reproductive medicine and
More informationHypothalamus & Pituitary Gland
Hypothalamus & Pituitary Gland Hypothalamus and Pituitary Gland The hypothalamus and pituitary gland form a unit that exerts control over the function of several endocrine glands (thyroid, adrenals, and
More informationPlan Now, Parent Later
Plan Now, Parent Later A GUIDE TO Fertility Preservation Options for Females 1 Author Barbara Lockart, DNP APRN/CNP CPON Lisa Bashore, PhD APRN CPNP CPON Contributor Barb Carr, MSN CPNP Debra Schmidt,
More information3 year old boy with puberty. Katie Stanley, MD August 1, 2013
3 year old boy with puberty Katie Stanley, MD August 1, 2013 Initial presentation 3 and 11/12 year old boy with signs of puberty Presented to outside endocrinologist in 2002 with: Pubic hair since 2.5
More informationINFERTILITY CAUSES. Basic evaluation of the female
INFERTILITY Infertility is the inability to conceive after 12 months of unprotected intercourse. There are multiple causes of infertility and a systematic way to evaluate the condition. Let s look at some
More informationChapter 2 Gonadotoxicity of Cancer Therapies in Pediatric and Reproductive-Age Males
Chapter 2 Gonadotoxicity of Cancer Therapies in Pediatric and Reproductive-Age Males Jill P. Ginsberg Introduction Recent epidemiological studies estimate that approximately 1 in every 1,300 young males
More informationKaren Syrjala, PhD Co-Director, Survivorship Program
Karen Syrjala, PhD Co-Director, Survivorship Program 1. Who are survivors of cancer? 2. Why do you care about your needs as a survivor? 3. What can you do to stay well as a survivor? Who are Survivors?
More informationLong Term Toxicity of Endocrine Therapy for premenopausal women with ER positive breast cancer
Global Breast Cancer Conference 2017 21 st Apr, 2017@Chezu Island Long Term Toxicity of Endocrine Therapy for premenopausal women with ER positive breast cancer Shinji Ohno, M.D., Ph.D., F.A.C.S. Breast
More informationPrevention and screening of long term side effects. Lena Specht MD DMSc Professor of Oncology Rigshospitalet, University of Copenhagen Denmark
Prevention and screening of long term side effects Lena Specht MD DMSc Professor of Oncology Rigshospitalet, University of Copenhagen Denmark Disclosures Member of Advisory Board and Principal Investigator,
More informationPrescribing Guidelines Prescribing arrangement for the management of patients transferring from Secondary Care to Primary Care
Berkshire West Integrated Care System Representing Berkshire West Clinical Commisioning Group Royal Berkshire NHS Foundation Trust Berkshire Healthcare NHS Foundation Trust Berkshire West Primary Care
More informationOne Day Hormone Check
One Day Hormone Check Patient: EMILY TEST DOB: January 18, 1948 Sex: F MRN: 0000000004 Order Number: J5070009 Completed: March 07, 2014 Received: March 07, 2014 Collected: March 07, 2014 Alec Smart, ND
More information1. Study Title. Exercise and Late Mortality in 5-Year Survivors of Childhood Cancer: a Report from the Childhood Cancer Survivor Study.
CCSS Analysis Concept Proposal Exercise, Mortality, & Childhood Cancer 1 1. Study Title. Exercise and Late Mortality in 5-Year Survivors of Childhood Cancer: a Report from the Childhood Cancer Survivor
More informationGynecologic Considerations in Women with FA
Gynecologic Considerations in Women with FA RAHEL GHEBRE, M.D., MPH University of Minnesota Medical School Objectives Recommendation for Gynecologic Care FA girls starting at age 16 should establish a
More informationCHEMOTHERAPY. Chemo, Ctx, Ctx. A category of cancer treatment that uses one or more anti-cancer drugs. Risk factor Male & Female
CHEMOTHERAPY Chemo, Ctx, Ctx A category of cancer treatment that uses one or more anti-cancer drugs. Risk factor Male & Female About Chemotherapy Chemotherapy is a category of cancer treatment that uses
More informationMartha Trout on 6/17/2012 at Pleasant Valley Cancer Center. Jane Plummer. Tom Plummer
SAMPLE This Survivorship Care Plan will facilitate cancer care following active treatment. It may include important contact information, a treatment summary, recommendations for follow-up care testing,
More informationStelios Mantis, MD DuPage Medical Group Pediatric Endocrinology
Stelios Mantis, MD DuPage Medical Group Pediatric Endocrinology 4 11 13 Initial Presentation Pt initially presented to pediatrician for school physical in fall 2012. Pt was found to be overweight (BMI:
More informationChildhood Cancer Survivor Study (U24 CA55727)
CCSS An NCI-funded Resource Childhood Cancer Survivor Study (U24 CA55727) Report of the Chronic Disease Working Group Charles Sklar, M.D. CCSS Investigator Meeting Williamsburg, VA June 9-10, 2010 Chronic
More informationChronic Disease Working Group CCSS Investigator Meeting 2015
Chronic Disease Working Group CCSS Investigator Meeting 2015 Kevin Oeffinger Charles (Chuck) Sklar Chronic Disease Working Group Next 10 yrs of CCSS may be more significant than the previous 10 yrs CCSS
More informationEffective risk-based therapy for childhood cancer has been the. Late Morbidity After Successful Treatment of Children with Cancer
PRINCIPLES &PRACTICE OF ONCOLOGY: RECENT ADVANCES Late Morbidity After Successful Treatment of Children with Cancer Smita Bhatia, MD, MPH,* and Louis S. Constine, MD Abstract: Over the last 4 decades,
More informationPaul Hofman. Professor. Paediatrician Endocrinologist Liggins Institute, The University of Auckland, Starship Children Hospital, Auckland
Professor Paul Hofman Paediatrician Endocrinologist Liggins Institute, The University of Auckland, Starship Children Hospital, Auckland 14:00-14:55 WS #108: Common pubertal variants how to distinguish
More informationDisclosures. This presentation is the intellectual property of the author. Contact them for permission to reprint and/or distribute.
ALL in AYAs: Health Outcomes as a Criterion for Selecting Optimal Therapy David R. Freyer, DO, MS Director, Survivorship and Supportive Care Program, Children s Center for Cancer and Blood Diseases, Children
More informationLate Effects after Transplantation for Pediatric Severe Aplastic Anemia. Jean E. Sanders, M.D.
Late Effects after Transplantation for Pediatric Severe Aplastic Anemia Jean E. Sanders, M.D. Patient Characteristics Acquired Fanconi Number 137 15 Gender F:M 63:74 9:6 Etiology: Idiopathic Hepatitis
More informationGrowth hormone therapy in a girl with Turner syndrome showing a large increase over the initially predicted ht of 4 5
Disorders of Growth and Puberty: How to Recognize the Normal Variants vs Patients Who Need to be Evaluated Paul Kaplowitz, M.D Pediatric Endocrinology. VCU School of Medicine Interpretation of Growth Charts
More information10/16/2014. Adolescents (ages 10 19) and young adults (ages 20 24) together compose about 21% of the population of the United States.
The purview of pediatrics includes the growth, development, and health of the child and therefore begins in the period before birth when conception is apparent. It continues through childhood and adolescence
More informationTherapeutic Cohort Results
Patient: JANE DOE DOB: December 31, 1968 Sex: F MRN: Order Number: Completed: February 26, 2016 Received: February 26, 2016 Collected: February 26, 2016 One Day Hormone Check - Salivary Profile Therapeutic
More informationCHILDHOOD CANCER SURVIVOR STUDY Long-Term Morbidity in Survivors of Childhood Leukemia with Down Syndrome Analysis Concept Proposal
CHILDHOOD CANCER SURVIVOR STUDY Long-Term Morbidity in of Childhood Leukemia with Down Syndrome Analysis Concept Proposal Working Group and Investigators Genetics Working Group & Chronic Disease Working
More informationTHE THYROID. Your thyroid evaluation may include the following:
An endocrinologist is a doctor specially trained to diagnose and treat diseases affecting your glands. Glands are small organs that produce hormones, which are substances that help control various activities
More informationHYPOTHALAMO PITUITARY GONADAL AXIS
HYPOTHALAMO PITUITARY GONADAL AXIS Physiology of the HPG axis Endogenous opioids and the HPG axis (exerciseinduced menstrual disturbances) Effects of the immune system on the HPG axis (cytokines: interleukins
More informationCCSS Neurology Committee Report: 6/08
Neurology Committee Report: 6/08 Roger J. Packer, MD Executive Director Neuroscience and Behavioral Medicine Chairman, Neurology Director, Brain Tumor Institute Children s s National Medical Center Washington,
More informationSecondary amenorrhoea Dr.ASMAA AL SANJARY
Secondary amenorrhoea Dr.ASMAA AL SANJARY The student at the end of this lecture should be able to: Define secondary amenorrhoea. Classify the causes of secondary amenorrhoea. Describe the commonest three
More informationInfertility History Form
Date form completed: Infertility History Form Patient s name: _ Age: Date of Birth: Occupation: Partner s name: Age: Date of Birth: Occupation: Prior marriage: Yes No # Prior marriage: Yes No # Attempted
More informationIdiopathic central precocious puberty associated with an enlarged pituitary gland
Idiopathic central precocious puberty associated with an enlarged pituitary gland Idiopathic central precocious puberty associated with an enlarged pituitary gland S Pathmanathan 1, Navoda Atapattu 2,
More informationLate effects, health status and quality of life after hemopoietic stem cell
Late effects, health status and quality of life after hemopoietic stem cell transplantation (HSCT) THE 13th ESH-EBMT TRAINING COURSE ON BLOOD AND MARROW TRANSPLANTATION EBMT Slide template Barcelona 7
More informationHypogonadism 4/27/2018. Male Hypogonadism -- Definition. Epidemiology. Objectives HYPOGONADISM. Men with Hypogonadism. 95% untreated.
Male Hypogonadism -- Definition - Low T, Low Testosterone Hypogonadism -...a clinical syndrome that results from failure of the testes to produce physiological concentrations of testosterone due to pathology
More informationHypothalamic Pituitary and Growth Disorders in Survivors of Childhood Cancer: An Endocrine Society* Clinical Practice Guideline
CLINICAL PRACTICE GUIDELINE Hypothalamic Pituitary and Growth Disorders in Survivors of Childhood Cancer: An Endocrine Society* Clinical Practice Guideline Charles A. Sklar, 1 Zoltan Antal, 1,2 Wassim
More informationReproductive System (Hormone Function) Physiology Department Medical School, University of Sumatera Utara
Reproductive System (Hormone Function) Physiology Department Medical School, University of Sumatera Utara 1 Endocrine Control: Three Levels of Integration Hormones of the hypothalamic-anterior pituitary
More information3. BACKGROUND AND RATIONALE
CHILDHOOD CANCER SURVIVOR STUDY Revised Analysis Concept Proposal 10-17 October 12, 2011 1. STUDY TITLE: Growth Hormone Exposure as a risk factor for the development of Subsequent Central Nervous System
More informationAMH and measuring Ovarian reserve
AMH and measuring Ovarian reserve Professor W Hamish Wallace Consultant Paediatric Oncologist Edinburgh Scotland UK hamish.wallace@nhs.net Ovarian Reserve? The Wallace-Kelsey Model (Five parameter asymmetric
More informationOne Day Hormone Check
One Day Hormone Check DOB: Sex: F MRN: Order Number: Completed: Received: Collected: Salivary Hormone Results Estradiol pmol/l >3330.0 Testosterone pmol/l
More informationGONADAL FUNCTION: An Overview
GONADAL FUNCTION: An Overview University of PNG School of Medicine & Health Sciences Division of Basic Medical Sciences Clinical Biochemistry BMLS III & BDS IV VJ Temple 1 What are the Steroid hormones?
More information